Product Description
Sodium benzoate is an organic sodium salt resulting from the replacement of the proton from the carboxy group of benzoic acid by a sodium ion. It has a role as an antimicrobial food preservative, a drug allergen, an EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor, an EC 3.1.1.3 (triacylglycerol lipase) inhibitor, an algal metabolite, a human xenobiotic metabolite and a plant metabolite. It contains a benzoate. (Sourced from: https://pubchem.ncbi.nlm.nih.gov/compound/Sodium-benzoate)
Mechanisms of Action: ALOX15 Inhibitor, LIP Inhibitor
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: *
Approval Status: Approved
Approved Countries: Algeria | Argentina | Australia | Belgium | Brazil | Chile | China | Egypt | France | Hong Kong | India | Ireland | Jordan | Korea | Lebanon | Malaysia | Morocco | New Zealand | Pakistan | Portugal | Russia | Saudi Arabia | Spain | Taiwan | Tunisia | Turkey | Ukraine | United Arab Emirates | United Kingdom | United States | Venezuela | Vietnam
Approved Indications: None
Known Adverse Events: None
Company: SyneuRx International (Taiwan) Corp
Company Location:
Company Founding Year: None
Additional Commercial Interests: None
Clinical Description
Countries in Clinic: Poland, Taiwan
Active Clinical Trial Count: 4
Recent & Upcoming Milestones
Highest Development Phases
Phase 3: Schizophrenia
Phase 2: Alzheimer Disease
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT05413655 |
EX-039-10701 | P2 |
Recruiting |
Alzheimer Disease |
2026-12-31 |
12% |
2025-02-28 |
Primary Completion Date|Primary Endpoints|Treatments |
2024-519237-34-00 |
SNR-05 | P3 |
Recruiting |
Schizophrenia |
2029-12-31 |
2025-05-02 |
Treatments |
|
2017-001170-42 |
2017-001170-42 | P3 |
Active, not recruiting |
Schizophrenia |
2021-07-12 |
2025-06-20 |
Treatments |
|
2017-001168-39 |
SNR-01-NaBen | P3 |
Active, not recruiting |
Schizophrenia |
2021-04-24 |
2022-03-13 |
Treatments |
Recent News Events
Date |
Type |
Title |
|---|---|---|
|
01/05/2026 |
News Article |
Flexible Plastic Bags Packaging Market worth $76.63 billion by 2030 - Exclusive Report by MarketsandMarkets™ |
|
12/18/2025 |
News Article |
Sodium Benzoate Market worth $372.3 million by 2030 at 4.1%, says MarketsandMarkets™ |
|
11/24/2025 |
News Article |
Sodium Benzoate Market worth $372.3 million by 2030 - Exclusive Report by MarketsandMarkets™ |
|
09/15/2025 |
News Article |
Curie Co and Microban International Partner to Advance Preservation Solutions for Cleaning, Paints and Coatings |